CN112839954A - 生产重组蛋白的方法 - Google Patents

生产重组蛋白的方法 Download PDF

Info

Publication number
CN112839954A
CN112839954A CN201980044908.3A CN201980044908A CN112839954A CN 112839954 A CN112839954 A CN 112839954A CN 201980044908 A CN201980044908 A CN 201980044908A CN 112839954 A CN112839954 A CN 112839954A
Authority
CN
China
Prior art keywords
cells
cell
batch
medium
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980044908.3A
Other languages
English (en)
Chinese (zh)
Inventor
徐建林
A·永基
田军
M·C·鲍里斯
李正剑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67470657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN112839954(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CN112839954A publication Critical patent/CN112839954A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN201980044908.3A 2018-07-03 2019-07-02 生产重组蛋白的方法 Pending CN112839954A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862693606P 2018-07-03 2018-07-03
US62/693,606 2018-07-03
PCT/US2019/040298 WO2020010080A1 (en) 2018-07-03 2019-07-02 Methods of producing recombinant proteins

Publications (1)

Publication Number Publication Date
CN112839954A true CN112839954A (zh) 2021-05-25

Family

ID=67470657

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980044908.3A Pending CN112839954A (zh) 2018-07-03 2019-07-02 生产重组蛋白的方法

Country Status (23)

Country Link
US (2) US20210253996A1 (https=)
EP (2) EP3818078B1 (https=)
JP (3) JP7419273B2 (https=)
KR (2) KR20250153311A (https=)
CN (1) CN112839954A (https=)
AU (1) AU2019299358B2 (https=)
CA (1) CA3104684A1 (https=)
DK (1) DK3818078T3 (https=)
EA (1) EA202092904A1 (https=)
ES (1) ES2976708T3 (https=)
FI (1) FI3818078T3 (https=)
HR (1) HRP20240584T1 (https=)
HU (1) HUE066560T2 (https=)
IL (2) IL324666A (https=)
LT (1) LT3818078T (https=)
MX (1) MX2020013633A (https=)
PL (1) PL3818078T3 (https=)
PT (1) PT3818078T (https=)
RS (1) RS65472B1 (https=)
SG (1) SG11202012582QA (https=)
SI (1) SI3818078T1 (https=)
SM (1) SMT202400173T1 (https=)
WO (1) WO2020010080A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK181991B1 (en) * 2021-11-11 2025-05-15 Dsm Ip Assets Bv Combined fermentation process for producing one or more human milk oligosaccharide(s) (hmo(s)) in escherichia coli
WO2023242238A1 (en) * 2022-06-15 2023-12-21 UCB Biopharma SRL Cell culture processes
EP4339274B1 (en) 2022-09-13 2025-03-26 Sartorius Stedim Biotech GmbH Method for operating a bioprocess installation for production of a bioproduct
KR20240172522A (ko) * 2023-06-01 2024-12-10 (주)알테오젠 지속형 호르몬 수용체 길항제의 생산 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015133980A (ja) * 2004-08-27 2015-07-27 ファイザー・アイルランド・ファーマシューティカルズ 抗アミロイドベータ抗体の製法
JP2016000030A (ja) * 2006-09-13 2016-01-07 アッヴィ・インコーポレイテッド 細胞培養の改善

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
DE68919361T2 (de) 1988-06-21 1995-05-24 Genentech Inc Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
ES2193136T3 (es) 1991-08-14 2003-11-01 Genentech Inc Variantes de inmunoglubina para receptores especificos de fc epsilon.
AU687755B2 (en) 1992-08-21 1998-03-05 Genentech Inc. Method for treating an LFA-1-mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
ES2108566T3 (es) 1993-12-10 1997-12-16 Genentech Inc Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos.
WO1995019181A1 (en) 1994-01-18 1995-07-20 Genentech, Inc. A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
US5707622A (en) 1994-03-03 1998-01-13 Genentech, Inc. Methods for treating ulcerative colitis
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
JPH11507535A (ja) 1995-06-07 1999-07-06 イムクローン システムズ インコーポレイテッド 腫瘍の成長を抑制する抗体および抗体フラグメント類
CA2242414C (en) 1996-01-23 2012-01-03 Genentech, Inc. Anti-cd18 antibodies for use against stroke
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
EP0941344B1 (en) 1996-11-27 2004-05-19 Genentech, Inc. HUMANIZED ANTI-CD11a ANTIBODIES
KR100816621B1 (ko) 1997-04-07 2008-03-24 제넨테크, 인크. 항-ｖｅｇｆ 항체
ES2293682T5 (es) 1997-05-15 2011-11-17 Genentech, Inc. Anticuerpo anti-apo2.
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
ES2309012T3 (es) 1999-10-29 2008-12-16 Genentech, Inc. Composiciones del anticuerpo anti-psca y a sus procedimientos contra celulas cancerigenas que expresen psca.
HUE042314T2 (hu) 2011-02-07 2019-06-28 Cerenis Therapeutics Holding Sa Lipoprotein komplexek és azok gyártása és alkalmazásai
PT2837680T (pt) * 2011-07-01 2020-04-17 Amgen Inc Cultura celular de mamífero
WO2015095809A1 (en) * 2013-12-20 2015-06-25 Biogen Idec Ma Inc. Use of perfusion seed cultures to improve biopharmaceutical fed-batch production capacity and product quality
MA40021A (fr) * 2014-06-03 2015-12-10 Lupin Ltd Processus de culture cellulaire destiné à produire une protéine
AU2015269365A1 (en) * 2014-06-04 2016-12-15 Amgen Inc. Methods for harvesting mammalian cell cultures
US9813410B2 (en) 2014-06-26 2017-11-07 Rakuten, Inc. Information processing apparatus, information processing method, and information processing program

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015133980A (ja) * 2004-08-27 2015-07-27 ファイザー・アイルランド・ファーマシューティカルズ 抗アミロイドベータ抗体の製法
JP2016000030A (ja) * 2006-09-13 2016-01-07 アッヴィ・インコーポレイテッド 細胞培養の改善

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
MICHAEL POHLSCHEIDT等: ""Optimizing capacity utilization by large scale 3000 L perfusion in seed train bioreactors"", CELL CULTURE AND TISSUE ENGINEERING, vol. 29, no. 1, pages 1 *
元英进主编: "现代制药工艺学 上", 31 July 2004, 北京：化学工业出版社, , pages: 253 - 254 *
彭建新，杨红，洪华珠编著: "昆虫细胞生物技术", 31 December 2020, 武汉：华中师范大学出版社, , pages: 291 *
邱立友主编: "发酵工程与设备", 31 August 2007, 北京：中国农业出版社, , pages: 162 - 164 *
郑爱泉主编；杨振华，刘全永副主编: "现代生物技术概论", 31 August 2016, 重庆：重庆大学出版社, pages: 83 *

Also Published As

Publication number Publication date
US20210253996A1 (en) 2021-08-19
AU2019299358B2 (en) 2026-04-02
IL324666A (en) 2026-01-01
CA3104684A1 (en) 2020-01-09
IL279782A (en) 2021-03-01
WO2020010080A1 (en) 2020-01-09
PL3818078T3 (pl) 2024-04-29
EP4368699A2 (en) 2024-05-15
BR112020025623A2 (pt) 2021-03-23
IL279782B1 (en) 2026-01-01
SMT202400173T1 (it) 2024-07-09
JP2024050590A (ja) 2024-04-10
PT3818078T (pt) 2024-04-18
JP7419273B2 (ja) 2024-01-22
ES2976708T3 (es) 2024-08-07
EP3818078A1 (en) 2021-05-12
AU2019299358A1 (en) 2021-02-18
EP3818078B1 (en) 2024-02-28
FI3818078T3 (fi) 2024-05-14
DK3818078T3 (da) 2024-05-21
MX2020013633A (es) 2021-03-25
US20250171732A1 (en) 2025-05-29
JP2021529527A (ja) 2021-11-04
EP4368699A3 (en) 2024-09-11
KR20250153311A (ko) 2025-10-24
SI3818078T1 (sl) 2024-05-31
KR20210027427A (ko) 2021-03-10
HRP20240584T1 (hr) 2024-07-19
KR102870511B1 (ko) 2025-10-15
SG11202012582QA (en) 2021-01-28
LT3818078T (lt) 2024-04-25
RS65472B1 (sr) 2024-05-31
JP2026048825A (ja) 2026-03-17
HUE066560T2 (hu) 2024-08-28
EA202092904A1 (ru) 2021-04-22

Similar Documents

Publication Publication Date Title
US20250171732A1 (en) Methods of producing recombinant proteins
EA037568B1 (ru) Не содержащая сыворотки среда для культивирования клеток и способы ее применения
JP2023511291A (ja) 培養細胞から生産された生体物質を連続的に収穫するための装置及び方法
CN114514311A (zh) 改进补料分批细胞培养物中蛋白质产量的方法
US20180312802A1 (en) Methods for modulating production profiles of recombinant proteins in perfusion mode
US12486525B2 (en) Methods for increasing productivity of therapeutic proteins
US20200323958A1 (en) Methods for producing protein products
BR112020025623B1 (pt) Método para a produção, em grande escala, de um polipeptídeo recombinante de interesse
EA048403B1 (ru) Способы получения рекомбинантных белков
US20250115666A1 (en) Cell culture methods for producing therapeutic proteins
HK40002355A (en) Methods of decreasing trisulfide bonds during recombinant production of polypeptides
EA047026B1 (ru) Не содержащая сыворотки среда для культивирования клеток
EA050960B1 (ru) Не содержащая сыворотки среда для культивирования клеток

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination